Intrinsiqs

Is Biohaven Ltd. overvalued?

Biohaven Ltd. (BHVN) — key valuation metrics and fundamentals.

No verdict
Price
$13.82
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$2.09B
Dividend yield
0.0%
Return on equity
-2271.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BHVN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.